Urolithin A: The Gut Metabolite for Mitochondrial Health and Muscle Aging

Most longevity supplements operate primarily in the realm of animal studies and in-vitro cell experiments, with human evidence limited to surrogate biomarkers and short-duration trials. Urolithin A is different. As of 2022, it has a published randomized controlled trial in the prestigious journal Nature Aging showing measurable improvements in mitochondrial function, inflammatory markers, and muscle strength in healthy older adults. For a compound discovered less than 20 years ago, that's a remarkable evidentiary position.

Understanding urolithin A means understanding where it comes from, why most people don't make enough of it, and what the clinical evidence actually shows.

What Is Urolithin A?

Urolithin A (UA) is a urolithin — a class of benzocoumarins produced when intestinal bacteria metabolize ellagitannins, a type of polyphenol found in pomegranates, walnuts, raspberries, and strawberries.

The conversion pathway works like this:

Ellagitannins (from food) → Ellagic acid (released in the stomach) → Urolithins (produced by specific gut bacteria in the colon)

The specific bacterial species responsible for the conversion to UA include Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens, both relatively rare members of the gut microbiome. Population studies find that only 30–40% of adults harbor sufficient levels of these bacteria to be classified as "UA producers." The other 60–70% produce little to no urolithin A regardless of how much pomegranate juice they drink.

This is the core reason supplementation with synthesized UA is clinically relevant — it bypasses the microbial conversion step entirely.

How Urolithin A Works: The Mitophagy Mechanism

UA's primary mechanism is the induction of mitophagy — the selective autophagy (cellular self-cleaning) of damaged or dysfunctional mitochondria.

Mitochondria, the organelles responsible for ATP production, accumulate damage over time through oxidative stress and replication errors. Dysfunctional mitochondria produce more reactive oxygen species, consume more energy, and trigger inflammatory signaling. In healthy cells, mitophagy clears these damaged organelles and allows replacement with new, functional mitochondria.

Mitophagic capacity declines with age. In skeletal muscle, this contributes directly to the loss of muscle quality and function seen in aging (sarcopenia). In neurons, impaired mitophagy is implicated in Parkinson's disease pathology (the PINK1/Parkin pathway that activates mitophagy is one of the most frequently mutated pathways in familial Parkinson's).

UA activates mitophagy through the PINK1/Parkin pathway — the same pathway implicated in Parkinson's disease and essential for tagging damaged mitochondria for clearance. This isn't coincidental: restoring mitophagic flux in aging neurons and muscle cells is one of UA's most compelling therapeutic targets.

In C. elegans (roundworms), UA treatment extends lifespan by approximately 45%. In aged mice, UA supplementation improves exercise endurance and reduces inflammatory markers in skeletal muscle. In human cell culture, UA reliably increases LC3-II and other mitophagy markers.

The 2022 Nature Aging RCT: Human Evidence

The landmark clinical trial was published in Nature Aging in June 2022 (Andreux et al.). This was a randomized, double-blind, placebo-controlled trial — the highest evidence tier for clinical interventions.

Study design:

• 66 healthy older adults (65–90 years)
• Two doses of Mitopure (500 mg or 1,000 mg UA daily) vs. placebo
• Duration: 4 months

Primary findings at 1,000 mg/day:

• Mitochondrial gene expression: Significantly upregulated expression of genes involved in the electron transport chain and mitochondrial biogenesis in skeletal muscle biopsies
• Muscle strength: Significant improvements in handgrip strength and leg muscle strength at 4 months vs. baseline and vs. placebo
• Inflammatory markers: Significant reductions in plasma levels of IL-6, TNF-alpha, and other pro-inflammatory cytokines
• Safety: No significant adverse effects at either dose; well-tolerated across all participants

This was not a surrogate biomarker study — it measured skeletal muscle gene expression directly via biopsy, and measured functional strength outcomes. The 500 mg dose showed intermediate effects, with 1,000 mg showing the more consistent and statistically significant improvements.

An earlier 2019 trial in European Journal of Clinical Nutrition established safety and bioavailability of Mitopure across doses up to 2,000 mg/day, showing linear dose-response in plasma UA concentrations.

What Mitopure Is (and Why Generic UA Matters)

Mitopure is the branded, synthetic urolithin A produced by Amazentis (the Swiss longevity company that has done most of the clinical research). It's licensed to Timeline Nutrition for consumer products and is the form used in all published human RCTs.

Generic urolithin A supplements now exist from multiple manufacturers. The key consideration: bioavailability and purity of synthesized UA can vary considerably, and the clinical evidence base is specifically for Mitopure. Some generic products have third-party testing confirming purity; others do not.

When evaluating any UA supplement:

• Look for third-party testing (NSF, Informed Sport, or independent COA)
• Verify it specifies urolithin A (not "pomegranate extract" or "ellagic acid," which require conversion)
• Note the dose: the clinical evidence supports 1,000 mg/day

Taking a pomegranate extract supplement as a proxy for UA supplementation is not an equivalent strategy, for the reasons described above — the majority of people cannot convert ellagitannins to UA regardless of dose.

Who Is Urolithin A Most Relevant For?

Older adults concerned about muscle quality: The combination of mitophagy activation and the direct trial evidence for muscle strength improvements makes UA one of the most evidence-backed supplements for age-related muscle decline. It complements, rather than replaces, resistance training — the gold standard intervention for sarcopenia.

Active individuals over 40: Even before frank sarcopenia, mitochondrial quality in skeletal muscle affects exercise performance and recovery. UA's mitophagy-enhancing effects are relevant across the adult lifespan.

People with poor UA producer status: If you've undergone gut microbiome testing (via companies like Viome, Genova, or Diagnostic Solutions) and confirmed low or absent urolithin-producing species, supplementation is particularly rational.

Individuals interested in longevity biology: UA's mechanism is genuinely novel — it targets mitophagy via a specific pathway that is difficult to activate through other means. Fasting activates general autophagy but does not specifically target PINK1/Parkin-mediated mitophagy in the same way.

Combining Urolithin A with Other Longevity Compounds

UA works through a mechanism largely distinct from other common longevity supplements:

• NMN/NR: These raise NAD+ levels, supporting mitochondrial energy metabolism and sirtuin activity. UA's mitophagy mechanism and NAD+ precursor supplementation are complementary — UA clears damaged mitochondria, while NAD+ support improves the function of remaining ones.
• Spermidine: Activates general autophagy through a different mechanism (EP300 inhibition). Combining UA and spermidine may cover both general cellular cleanup and mitochondria-specific clearance.
• Quercetin: Works as a senolytic and general autophagy inducer. The combination of UA + quercetin is under preclinical investigation.
• Resistance training: Exercise is the most powerful stimulus for mitochondrial biogenesis. UA and exercise appear to work synergistically — exercise creates the demand for high-quality mitochondria, while UA helps clear the damaged ones that would otherwise limit adaptation.

Dosing and Practical Considerations

Established clinical dose: 1,000 mg/day of urolithin A (the dose used in the 2022 Nature Aging trial). The 500 mg dose showed trends but less consistent statistical significance.

Timing: UA can be taken with or without food. There is no strong evidence for a specific timing advantage.

Duration: The 4-month trial showed meaningful improvements. Urolithin A is intended for ongoing, consistent use — mitophagy is a continuous cellular process, not a one-time event.

Safety profile: Across human trials, UA at up to 2,000 mg/day showed no significant adverse effects. It does not appear to interact meaningfully with common medications based on available data, but as with any supplement, individuals on complex medication regimens should consult a healthcare provider.

The Bottom Line

Urolithin A is produced when specific gut bacteria convert ellagitannins from pomegranate and berries — but the majority of adults lack sufficient levels of these bacteria to produce meaningful amounts from food. Supplementation with synthesized UA (specifically at 1,000 mg/day as studied in Mitopure trials) bypasses this limitation and delivers measurable effects on mitochondrial gene expression, inflammatory markers, and muscle strength in aging adults, as demonstrated in a 2022 Nature Aging RCT. For anyone over 40 focused on maintaining muscle quality and mitochondrial function as they age, urolithin A has one of the strongest evidence profiles of any longevity supplement currently available.

---

Longevity supplements work best when they're part of a coordinated strategy. Use Optimize free to track your stack, monitor your response, and ensure your supplements are working together effectively.

Related Articles

• Urolithin A: Mitophagy, Muscle, and Longevity